{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:35:33Z","timestamp":1790156133486,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jdermsci.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:51:09Z","timestamp":1759539069000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A reappraisal of type 2 cytokine-producing cells in atopic dermatitis: Spotlight on Tc2 cells"],"prefix":"10.1016","volume":"120","author":[{"given":"Tetsuya","family":"Honda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2025.09.006_bib1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/all.13320","article-title":"The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies","volume":"73","author":"Abuabara","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/intimm\/dxy015","article-title":"Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers","volume":"30","author":"Nomura","year":"2018","journal-title":"Int Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41423-025-01261-2","article-title":"Type 2 immunity in allergic diseases","volume":"22","author":"Ogulur","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"He","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jaci.2020.03.041","article-title":"Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis","volume":"146","author":"Rojahn","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2749","article-title":"Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Ralpha blockade","volume":"6","author":"Bangert","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaci.2023.04.019","article-title":"Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis","volume":"152","author":"Alkon","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib10","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/s41467-024-46540-0","article-title":"Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded t cells","volume":"15","author":"Bangert","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1084\/jem.155.3.914","article-title":"Identification of a t cell-derived b cell growth factor distinct from interleukin 2","volume":"155","author":"Howard","year":"1982","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1084\/jem.155.3.734","article-title":"T cell-derived b cell differentiation factor(s). effect on the isotype switch of murine b cells","volume":"155","author":"Isakson","year":"1982","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/319640a0","article-title":"Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter","volume":"319","author":"Noma","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib14","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper t cell clone. I. definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.142.2.679","article-title":"A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes","volume":"142","author":"Brown","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/325537a0","article-title":"Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage","volume":"325","author":"Ohara","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib18","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1073\/pnas.84.6.1669","article-title":"Characterization of the high-affinity cell-surface receptor for murine B-cell-stimulating factor 1","volume":"84","author":"Park","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000234661","article-title":"Immunoglobulin e and immunoglobulin g subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis","volume":"87","author":"Reinhold","year":"1988","journal-title":"Int Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib20","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.4049\/jimmunol.144.12.4651","article-title":"Evidence for compartmentalization of functional subsets of CD2+ t lymphocytes in atopic patients","volume":"144","author":"Wierenga","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1523-1747.ep12480966","article-title":"High frequency of IL-4-producing CD4+ allergen-specific t lymphocytes in atopic dermatitis lesional skin","volume":"97","author":"van der Heijden","year":"1991","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0091-6749(92)90434-4","article-title":"House dust mite-specific t cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test","volume":"89","author":"Sager","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0140-6736(94)90879-6","article-title":"Lesional expression of interferon-gamma in atopic eczema","volume":"343","author":"Grewe","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI117408","article-title":"Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis","volume":"94","author":"Hamid","year":"1994","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1365-2249.1997.4671365.x","article-title":"IL-13 over-expression in skin is not confined to IgE-mediated skin inflammation","volume":"109","author":"Van der Ploeg","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00403-004-0455-6","article-title":"Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis","volume":"295","author":"Tazawa","year":"2004","journal-title":"Arch. Dermatol. Res"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib27","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13-Dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/exd.13911","article-title":"Understanding the immune landscape in atopic dermatitis: the era of biologics and emerging therapeutic approaches","volume":"28","author":"Moyle","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","article-title":"Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes","volume":"9","author":"Junttila","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111933","article-title":"Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway","volume":"42","author":"Nunomura","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/eji.202149677","article-title":"IL-13 in dermal type-2 dendritic cell specialization: from function to therapeutic targeting","volume":"52","author":"Lamiable","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons Co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1172\/JCI0215753","article-title":"Allergen-specific CD8(+) t cells and atopic disease","volume":"110","author":"Seneviratne","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anai.2020.08.016","article-title":"New treatments in atopic dermatitis","volume":"126","author":"Puar","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/bjd\/ljae230","article-title":"The role of OX40 ligand\/OX40 axis signalling in atopic dermatitis","volume":"191","author":"Guttman-Yassky","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jaci.2020.02.008","article-title":"Reconciling innate and acquired immunity in atopic dermatitis","volume":"145","author":"Honda","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib37","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib38","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.180.5.1715","article-title":"Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles","volume":"180","author":"Croft","year":"1994","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib39","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.181.3.1229","article-title":"Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia","volume":"181","author":"Coyle","year":"1995","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib40","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41385-018-0049-9","article-title":"Synergistic activation of pro-inflammatory type-2 CD8(+) t lymphocytes by lipid mediators in severe eosinophilic asthma","volume":"11","author":"Hilvering","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaci.2019.07.022","article-title":"Is there a role for type 2 CD8(+) t cells in patients with steroid-resistant asthma?","volume":"144","author":"Gelfand","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib42","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0092-2019","article-title":"CD8(+) Tc2 cells: underappreciated contributors to severe asthma","volume":"28","author":"Hinks","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib43","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.2001245","article-title":"The roles of type 2 cytotoxic t cells in inflammation, tissue remodeling, and prostaglandin (PG) D(2) production are attenuated by PGD(2) receptor 2 antagonism","volume":"206","author":"Chen","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib44","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.jaci.2018.11.049","article-title":"Hypoxia enhances CD8(+) T(C)2 cell-dependent airway hyperresponsiveness and inflammation through hypoxia-inducible factor 1alpha","volume":"143","author":"Ning","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib45","first-page":"107","article-title":"Antigen-specific activities of CD8+ t cells in the nasal mucosa of patients with nasal allergy","volume":"30","author":"Qiu","year":"2012","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib46","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1365-2222.2004.02009.x","article-title":"Induction of t 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ t cells expressing peripheral tissue trafficking markers","volume":"34","author":"Gardner","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are TH2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-101320-030339","article-title":"Emerging paradigms in type 2 immunity","volume":"40","author":"Hammad","year":"2022","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2025.09.006_bib49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.immuni.2023.03.014","article-title":"The ins and outs of innate and adaptive type 2 immunity","volume":"56","author":"Molofsky","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2025.09.006_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat1604","article-title":"Type 2 immunity: expanding our view","volume":"3","author":"Lloyd","year":"2018","journal-title":"Sci. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T15:26:55Z","timestamp":1766590015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181125001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0923181125001793"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.09.006","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A reappraisal of type 2 cytokine-producing cells in atopic dermatitis: Spotlight on Tc2 cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}